CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA PATIENTS AT THE UNIT OF HEPATOBILIARY CANCER AND LIVER TRANSPLANT – HBP SURGERY DEPARTMENT IN THE UNIVERSITY MEDICAL CENTER HO CHI MINH CITY

Trần Quang Tú1, Trần Công Duy Long2, Đỗ Thị Hồng Tươi1,
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 University Medical Center Ho Chi Minh City

Main Article Content

Abstract

Background: In Viet Nam, hepatocellular carcinoma (HCC) is currently the type of cancer leading in both incidence and mortality rates. Objectives: To determine the pathological characteristics and test results of HCC patients. Materials and methods: This prospective cross-sectional study recorded the pathological characteristics and test results of 220 HCC patients hospitalized for inpatient treatment at the Unit of Hepatobiliary cancer and Liver transplant – HBP surgery department, the University Medical Center Ho Chi Minh city from October 2020 to April 2021. Results: Male patients accounted for the majority, the incidence of HCC increased with age, with 39.4% male patients between 61-70 years old and 44.0% female patients over 70 years old. Most HCC patients were detected at stages A-B, in which women tend to detect HCC earlier (56.0% stage A) than men (51.2% stage B). The risk factors accounting for a high proportion were hepatitis (87.7%) (mainly hepatitis B accounting for 65.5%), and alcohol consumption (69.5%). The common tumor size was 3-5 cm (46.4%), tumors usually appear on the right liver (55.5%). The mean values of liver damage tests (GOT, GPT, GGT), and liver cancer markers (AFP, % AFP-L3, PIVKA-II) were all higher than normal values. However, there was still a certain percentage of patients with HCC but normal liver cancer markers. Conclusion: There is a division of HCC patients by sex, age, and disease stage. Hepatitis and alcohol are the two main risk factors for HCC. The test results reflect liver damage and some liver functions are affected, but some patients with HCC still have liver cancer markers that are normal.

Article Details

References

1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209-249.
2. Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019). A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature reviews. Gastroenterology & hepatology, 16(10), 589-604.
3. Galle, P. R., Foerster, F., Kudo, M., Chan, S. L., Llovet, J. M., Qin, S., … Zhu, A. X. (2019). Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver international: official journal of the International Association for the Study of the Liver, 39(12), 2214-2229.
4. Phạm Cẩm Phương, Mai Trọng Khoa và CS. (2019). Xét nghiệm AFP, AFP-L3 và PIVKA-II huyết thanh ở bệnh nhân ung thư biểu mô tế bào gan tại Bệnh viện Bạch Mai. Tạp chí Ung thư học Việt Nam. 2019, tr.301-306.
5. Lê Hữu Phước, Bành Vũ Điền (2011). Đặc điểm lâm sàng và cận lâm sàng bệnh nhân ung thư tế bào gan (HCC) tại khoa nghiên cứu và điều trị viêm gan Bệnh viện Chợ Rẫy. Tạp chí Y học TP. Hồ Chí Minh. Tập 15(4)-2011: tr.570-572.
6. Phạm Thanh Bình, Hoàng Thị Minh và CS. (2018). Khảo sát đặc điểm lâm sàng, cận lâm sàng và nồng độ AFP, PIVKA-II ở bệnh nhân ung thư biểu mô tế bào gan. Tạp chí Y Dược thực hành 175. Tập 15-2018: tr.60-67.
7. Nguyễn Trung Kiên, Nguyễn Thị Hồng Lê (2017). Khảo sát đặc điểm hình ảnh và giá trị của siêu âm, chụp cắt lớp vi tính ung thư biểu mô tế bào gan tại Bệnh viện Quân Y 4. Tạp chí Y Dược học quân sự. Tập 1-2017: tr.105-111.
8. Kim, G. A., Kim, H. I., Chang, S., An, J., Lee, D., Lee, H. C., Han, S., & Shim, J. H. (2019). A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma. American journal of clinical oncology, 42(7), 555–563.
9. Chie, W. C., Yu, F., Li, M., Baccaglini, L., Blazeby, J. M., Hsiao, C. F., Chiu, H. C., Poon, R. T., Mikoshiba, N., Al-Kadhimi, G., Heaton, N., Calara, J., Collins, P., Caddick, K., Costantini, A., Vilgrain, V., & Chiang, C. (2015). Quality of life changes in patients undergoing treatment for hepatocellular carcinoma. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 24(10), 2499–2506.